. Author manuscript; available in PMC: 2021 Dec 1.

Published in final edited form as: J Am Geriatr Soc. 2020 Oct 1;68(12):2921–2926. doi: 10.1111/jgs.16844

Table 1.

Examples of medication aggregation within SAGES^A

Medication Group	Medication Class	Individual Medication^B	Inpatient Prevalence^B n (%)	Aggregated Medication Groups	Inpatient Prevalence n (%)^A
Central Nervous System (28.00)	Opiate Agonists (28.08.08)	HYDROmorphone oxyCODONe morphine traMADol HYDROcodone fentaNYL codeine meperidine methadone	409 (73.0) 421 (75.2) 125 (22.3) 35 (6.3) 20 (3.6) 19 (3.4) 1 (0.2) 1 (0.2) 1 (0.2)	HYDROmorphone oxyCODONe morphine traMADol Other opioids	409 (73.0) 421 (75.2) 125 (22.3) 35 (6.3) 42 (7.5)
	Benzodiazepines (28.24.04)	LORazepam diazePAM ALPRAZolam clonazePAM temazepam triazolam oxazepam midazolam	46 (8.2) 43 (7.7) 8 (1.4) 7 (1.3) 3 (0.5) 3 (0.5) 2 (0.4) 1 (0.2)	Benzodiazepines	113 (20.2)
	Antipsychotics (28.16.08)	haloperidol prochlorperazine QUEtiapine OLANZapine chlorproMAZINE	15 (2.7) 9 (1.6) 7 (1.3) 3 (0.5) 1 (0.2)	Antipsychotics	35 (6.3)

Only medications administered to at least 1 patient from a class are reported.

Numbers in parentheses represent the AHFS code corresponding to the presented categories.¹⁹